Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DKSH Business Unit Healthcare has signed a regional agreement with Cheplapharm, a German marketer of medicinal products, food supplements and cosmetics, to provide product registration and distribution services in Asia.
Subscribe to our email newsletter
Under the deal, DKSH will be responsible for providing registration, importation, warehousing, physical distribution and collection services for Cheplapharm’s products Vesanoid (Tretinoin) and Rohypnol (Flunitrazepam) in Brunei, Hong Kong, Korea, Laos, Malaysia, Singapore, Thailand, and Vietnam.
Cheplapharm head of International Sales & Project Management Norman Braun said, "The decision to partner with DKSH across Asia for the registration and distribution of our products is based on their regional service platform, their unrivalled access to patients and their ability to maintain the integrity of the value chain across several markets in Asia."
DKSH Thailand regional business development director of Pharmaceuticals, Business Unit Healthcare Thomas Delemazure said, "We are delighted to partner with Cheplapharm in eight markets and look forward to helping them to grow their business with our Market Expansion Services."
The deal underlines DKSH’s position as partner of choice for healthcare companies wanting to focus on their core competencies while ensuring their growth in Asia.
The deal will further strengthen DKSH’s market position in Asia as well as contribute incrementally to the Group’s overall profitability over time.